BMY logo

Bristol-Myers Squibb (BMY) Company Overview

Profile

Full Name:

Bristol-Myers Squibb Company

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

United States

IPO:

June 1, 1972

Indexes:

S&P 500

Website:

http://www.bms.com

Description:

Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, licensing, manufacturing, marketing, and sale of biopharmaceutical products. Bristol-Myers pharmaceutical products are chemically synthesized or low molecular weight drugs for the following therapeutic areas: oncology; immunology with priorities in psoriasis, lupus, cancer, inflammatory bowel diseases, HIV; cardiovascular with priority in heart disease; fibrotic diseases of the lungs and liver; hepatitis B, C. The line of pharmaceuticals is represented by 10 trade brands. The Bristol-Myers company was registered in 1933 and essentially is the successor of a New York pharmaceutical manufacturer that has been in operation since 1887. Bristol-Myers' major manufacturing facilities are located in the United States, Puerto Rico, Ireland, France, and Italy.

Key Details

Price

$61.05

Market Cap

$123.89 B(Mega cap)

Last Dividend

$0.62

TTM Dividend Yield

3.96%

Annual Revenue

$48.30 B(+7.32% YoY)

Annual EPS

-$4.41(-214.25% YoY)

PE Ratio

-

Annual ROE

-39.01%

Annual Debt To Equity

3.04

Beta

0.03

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

Apr 4, 2025

Recent ex-dividend date:

Jan 3, 2025
Splits

Next split:

N/A

Recent split:

Aug 7, 2001

Analyst ratings

Recent major analysts updates

Feb 7, 25 Wells Fargo
Equal-Weight
Feb 4, 25 Cantor Fitzgerald
Neutral
Jan 28, 25 Citigroup
Neutral
Jan 8, 25 Truist Securities
Buy
Dec 16, 24 Jefferies
Buy
Nov 15, 24 Wolfe Research
Peer Perform
Nov 12, 24 Morgan Stanley
Underweight
Nov 12, 24 Leerink Partners
Outperform
Nov 12, 24 Citigroup
Neutral
Nov 12, 24 BMO Capital
Market Perform

Screeners with BMY included

Growing Shares Outstanding
US stocks
S&P 500 companies earnings calendar
Stocks recommended to hold
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$61.05
BMY price is $61.05

Price All-time High

$81.13
BMY price is currently -24.75% below its historical high of $81.13

Price Analysts Target

$62.00
BMY price is currently -1.54% lower than the consensus analysts' forecast

Price Most Recent Change

+1.51%
BMY price was up +1.51% on Mar 8, 2025

Price YTD Change

+7.94%
BMY price is up +7.94% since January 1st

Price 3-Year Change

-11.23%
BMY price is down -11.23% over the past 3 years

Market cap

Market Cap

$123.89 B
BMY market capitalization is $123.89 billion

Market Cap 3-Year Change

-17.35%
BMY market capitalization is down -17.35% over the past 3 years

Market Cap All-time High

$172.50 B
BMY market capitalization is currently -28.18% below its historical high of $172.50 billion

Market Cap Sector Rank

98.44%
BMY market capitalization is higher than 98.44% of companies in Healthcare sector

Technical

Beta

0.03
BMY beta is 0.03

200-day SMA

$51.38
BMY price is currently +18.81% above its 200-day simple moving average

14-day RSI

65.90
BMY 14-day relative strength index is 65.90

30-day Relative Volume

1.51
BMY 30-day relative volume is 1.51

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.62
BMY last dividend was $0.62 per share, with an ex-dividend date of January 3, 2025

Next Dividend

$0.62
BMY has announced a dividend of $0.62 per share, with an ex-dividend date set for April 4, 2025

Dividend per share

Annual Dividend Per Share

$2.40
BMY annual dividend per share is $2.40

Annual Dividend Per Share Sector Rank

75.9%
BMY annual dividend per share is higher than 75.9% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+5.26%
BMY annual dividend per share is up +5.26% year-on-year

Annual Dividend Per Share 3-Year Change

+22.45%
BMY annual dividend per share is up +22.45% over the past 3 years

Dividend yield

Annual Dividend Yield

3.93%
BMY annual dividend yield is 3.93%

Annual Dividend Yield Sector Rank

81.71%
BMY annual dividend yield is higher than 81.71% of companies in Healthcare sector

Other

Annual Payout Ratio

-54.35%
BMY annual payout ratio is -54.35%

Annual Dividends Paid

$4.86 B
BMY annual dividends paid is $4.86 billion

Annual FCF

$13.94 B
BMY annual free cash flow is $13.94 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$48.30 B
BMY annual revenue is $48.30 billion

Annual Revenue Analysts Estimate

$45.65 B
BMY annual revenue is currently +5.82% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+7.32%
BMY annual revenue is up +7.32% year-on-year

Annual Revenue Sector Rank

98.16%
BMY annual revenue is higher than 98.16% of companies in Healthcare sector

Profit

Annual Gross Profit

$34.33 B
BMY annual gross profit is $34.33 billion

Annual Gross Margin

71.08%
BMY annual gross profit margin is 71.08%

Annual Operating Profit

$5.89 B
BMY annual operating income is $5.89 billion

Annual Operating Margin

12.19%
BMY annual operating profit margin is 12.19%

Annual Net Income

-$8.95 B
BMY annual net profit is -$8.95 billion

Annual Net Margin

-18.53%
BMY annual net profit margin is -18.53%

EPS

Annual EPS

-$4.41
BMY annual earnings per share is -$4.41

Annual EPS Analysts Estimate

$6.75
BMY annual earnings per share is currently -165.35% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-214.25%
BMY annual earnings per share is down -214.25% year-on-year

Annual EPS Sector Rank

25.13%
BMY annual earnings per share is higher than 25.13% of companies in Healthcare sector

ROA & ROE

Annual ROA

-9.53%
BMY annual return on assets is -9.53%

Annual ROE

-39.01%
BMY annual return on equity is -39.01%

EBIT & EBITDA

Annual EBIT

-$6.43 B
BMY annual earnings before interest & taxes is -$6.43 billion

Annual EBITDA

$2.44 B
BMY annual EBITDA is $2.44 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BMY price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BMY price to earnings ratio is unknown

PB Ratio

PB Ratio

7.58
BMY price to book ratio is 7.58

PB Ratio Sector Rank

88.71%
BMY price to book ratio is higher than 88.71% of companies in Healthcare sector

PS Ratio

PS Ratio

2.56
BMY price to sales ratio is 2.56

PS Ratio Sector Rank

46.15%
BMY price to sales ratio is higher than 46.15% of companies in Healthcare sector

Enterprise value

Enterprise Value

$164.74 B
BMY enterprise value is $164.74 billion

Enterprise Value Sector Rank

98.92%
BMY enterprise value is higher than 98.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

55.26
BMY EV/EBITDA is 55.26

EV/EBITDA Sector Rank

97.29%
BMY EV/EBITDA is higher than 97.29% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.25
BMY annual current ratio is 1.25

Annual Quick Ratio

0.33
BMY annual quick ratio is 0.33

Leverage

Annual Debt To Equity

3.04
BMY annual debt to equity ratio is 3.04

Annual Interest Coverage Ratio

-3.30
BMY annual interest coverage ratio is -3.30

Risk & Stability

Piotroski F-Score

4
BMY piotroski f-score is 4

Altman Z-Score

1.57
BMY altman z-score is 1.57

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$92.60 B
BMY annual total assets is $92.60 billion

Annual Non Current Assets

$62.82 B
BMY annual long term assets is $62.82 billion

Annual Current Assets

$10.35 B
BMY annual total current assets is $10.35 billion

Annual Cash & Cash Equivalents

$10.35 B
BMY annual cash & cash equivalents is $10.35 billion

Equity

Annual Book Value

$16.34 B
BMY annual book value is $16.34 billion

Annual Working Capital

$6.01 B
BMY annual working capital is $6.01 billion

Liabilities

Annual Total Liabilities

$76.22 B
BMY annual total liabilities is $76.22 billion

Annual Total Long Term Liabilities

$52.44 B
BMY annual total long term liabilities is $52.44 billion

Annual Current Liabilities

$23.77 B
BMY annual total current liabilities is $23.77 billion

Annual Accounts Payable

$3.60 B
BMY annual accounts payable is $3.60 billion

Debt

Annual Total Debt

$51.20 B
BMY annual total debt is $51.20 billion

Annual Total Debt 1-Year Change

+23.48%
BMY annual total debt is up +23.48% year-on-year

Annual Long Term Debt

$48.97 B
BMY annual long term debt is $48.97 billion

Annual Short Term Debt

$2.23 B
BMY annual short term debt is $2.23 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$42.41 B
BMY annual total expenses is $42.41 billion

Annual Operating Expenses

$28.45 B
BMY annual total operating expenses is $28.45 billion

Annual Cost Of Goods Sold

$13.97 B
BMY annual cost of goods sold is $13.97 billion

Annual SGA

$8.41 B
BMY annual SGA is $8.41 billion

Annual D&A

$9.60 B
BMY annual depreciation & amortization is $9.60 billion

Annual Interest Expense

$1.95 B
BMY annual interest expense is $1.95 billion

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$15.19 B
BMY annual cash flow from operations is $15.19 billion

Annual CFO 1-Year Change

+9.6%
BMY annual cash flow from operations is up +9.6% year-on-year

Annual CFI

-$21.35 B
BMY annual cash flow from investing activities is -$21.35 billion

Annual CFI 1-Year Change

-830.37%
BMY annual cash flow from investing activities is down -830.37% year-on-year

Annual CFF

$5.13 B
BMY annual cash flow from financing activities is $5.13 billion

Annual CFF 1-Year Change

+154.45%
BMY annual cash flow from financing activities is up +154.45% year-on-year

Free CashFlow

Annual FCF

$13.94 B
BMY annual free cash flow is $13.94 billion

Annual FCF 1-Year Change

+10.2%
BMY annual free cash flow is up +10.2% year-on-year

CAPEX

Annual CAPEX

$1.25 B
BMY annual capital expenditures is $1.25 billion

Annual CAPEX 1-Year Change

+3.23%
BMY annual capital expenditures is up +3.23% year-on-year

Institutional Ownership

Similar stocks

VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
MDT logo
Medtronic (MDT)
BSX logo
Boston Scientific (BSX)
SYK logo
Stryker (SYK)
GILD logo
Gilead Sciences (GILD)
SNY logo
Sanofi (SNY)
PFE logo
Pfizer (PFE)
DHR logo
Danaher (DHR)
ELV logo
Elevance Health (ELV)

FAQ

  • What is the ticker symbol for Bristol-Myers Squibb?
  • Does Bristol-Myers Squibb pay dividends?
  • What sector is Bristol-Myers Squibb in?
  • What industry is Bristol-Myers Squibb in?
  • What country is Bristol-Myers Squibb based in?
  • When did Bristol-Myers Squibb go public?
  • Is Bristol-Myers Squibb in the S&P 500?
  • Is Bristol-Myers Squibb in the NASDAQ 100?
  • Is Bristol-Myers Squibb in the Dow Jones?
  • When was Bristol-Myers Squibb's last earnings report?
  • When does Bristol-Myers Squibb report earnings?
  • Should I buy Bristol-Myers Squibb stock now?

What is the ticker symbol for Bristol-Myers Squibb?

The ticker symbol for Bristol-Myers Squibb is NYSE:BMY

Does Bristol-Myers Squibb pay dividends?

Yes, Bristol-Myers Squibb pays dividends. The last payment was $0.62, with an ex-dividend date on January 3, 2025

What sector is Bristol-Myers Squibb in?

Bristol-Myers Squibb is in the Healthcare sector

What industry is Bristol-Myers Squibb in?

Bristol-Myers Squibb is in the Drug Manufacturers - General industry

What country is Bristol-Myers Squibb based in?

Bristol-Myers Squibb is headquartered in United States

When did Bristol-Myers Squibb go public?

Bristol-Myers Squibb's initial public offering (IPO) was on June 1, 1972

Is Bristol-Myers Squibb in the S&P 500?

Yes, Bristol-Myers Squibb is included in the S&P 500 index

Is Bristol-Myers Squibb in the NASDAQ 100?

No, Bristol-Myers Squibb is not included in the NASDAQ 100 index

Is Bristol-Myers Squibb in the Dow Jones?

No, Bristol-Myers Squibb is not included in the Dow Jones index

When was Bristol-Myers Squibb's last earnings report?

Bristol-Myers Squibb's most recent earnings report was on Feb 6, 2025

When does Bristol-Myers Squibb report earnings?

The next expected earnings date for Bristol-Myers Squibb is Apr 24, 2025

Should I buy Bristol-Myers Squibb stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions